LMR Partners LLP - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 52 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 18.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
LMR Partners LLP ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$62,000
+129.6%
19,285
+91.0%
0.00%
-66.7%
Q2 2015$27,00010,0990.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders